期刊文献+

雄黄中砷对大鼠肝肾功能的影响 被引量:7

Effects of Arsenic in Realgar on Rats Hepatic and Renal Function
下载PDF
导出
摘要 【目的】采用混合效应线性模型评价不同毒性剂量雄黄在大鼠体内的血砷浓度变化及对其肝肾功能的影响。【方法】选用SD大鼠分别单次灌服3.738、1.869、0.935 g/kg雄黄,测定不同剂量组大鼠药后各时间点/段血砷浓度及尿N-乙酰-β-D-氨基葡萄糖苷酶(NAG)、碱性磷酸酶(AKP)活性,血清天门冬氨酸氨基转移酶(GOT)、丙氨酸氨基转移酶(GPT)、肌酐(Cr)、尿素氮(BUN)活力,并采用混合效应线性模型对其进行统计分析。【结果】大鼠单次灌服不同剂量雄黄,尿AKP、NAG活力,血清BUN、GOT活力的改变有显著的剂量依赖关系,并与血砷浓度变化有显著的线性关系。【结论】在本研究剂量范围内,雄黄中的砷可造成肾小管上皮细胞及肝脏的损伤,但未影响到肾脏的排泄能力。 Objective To investigate the influence of blood arsenic concentration change on hepatic and renal function of rats administered with different toxic dosages of realgar by applying the linear mixed-effects model.Methods SD rats were given gastric gavage of realgar at the single dose of 3.738g/kg,1.869 g/kg and 0.935 g/kg respectively.After administration,the concentration of blood arsenic,the activities of urine alkaline phosphatase(AKP),N-acetyl-beta-D-glucosaminidase(NAG),serum glutamic oxaloacetic transaminase(GOT) and glutamate-pyruvate transaminase(GPT) activities,serum creatinine(Cr) level,and blood urea nitrogen(BUN) content were detected in different groups at different time points.The detection results were analyzed with the linear mixed-effects model.Results The changes of urine AKP and NAG activities,serum BUN content and serum GOT activity were presented in a dose-dependent manner,and had linear correlation with arsenic concentration.Conclusion In the dose range of 0.935 to 3.738 g/kg,realgar can cause the hepatic damage and the injury of tubular epithelial cells of kidney,but has not affected the renal excretion.
出处 《广州中医药大学学报》 CAS 2010年第4期375-383,共9页 Journal of Guangzhou University of Traditional Chinese Medicine
基金 国家自然科学基金资助项目(编号:30672637)
关键词 雄黄/毒性 砷/血液 肝肾功能 混合效应线性模型 大鼠 REALGAR/toxicity ARSENIC/blood HEPATIC AND RENAL FUNCTION LINEAR MIXEDEFFECTS MODEL RATS
  • 相关文献

参考文献8

  • 1National Research Council (NRC). National Research Council report: arsenic in the drinking water [ M ]. Washington : National Academy Press, 1999: 101.
  • 2李国明,刘社清,张雪静.雄黄对小鼠肾脏形态学的影响[J].河北医药,2002,24(1):60-60. 被引量:11
  • 3Santra A, Maiti A, Das S, et al. Hepatic damage caused by chronic arsenic toxicity in experimental animals [ J]. J Toxicol Clin Toxicol, 2000, 38: 395.
  • 4郝琨,柳晓泉,王广基.临床前毒代动力学研究进展[J].中国药科大学学报,2004,35(3):195-199. 被引量:12
  • 5胡良平.第十六讲 如何比较重复测量结果[J].中华预防医学杂志,2003,37(4):293-294. 被引量:11
  • 6Wang M, Borders B E, Zhao D. An empirical comparison of two subject-specific approaches to dominant heights modeling: The dummy variable method and the mixed model method [ J]. Forest Ecology and Management, 2008, 255 (7) : 2659.
  • 7Pinheiroc J, Bates D M. Mixed-effects models in S and S-PLUS [M]. New York: Springer, 2000: 8.
  • 8Jolling K, Perez Ruixo J J, Hemeryck A, et al. Mixed-effect modeling of the interspecies pharmacokinetic scaling of pegylated human erythropoietin [ J ]. Eur J Pharm Sci, 2005, 24 (5) : 465.

二级参考文献21

  • 1Baldrick P.Pharmaceutical development: the need for preclinical guidance[J].Regul Toxicol Pharmacol,2000,32(3):210-218.
  • 2Morgan DG,Kelvin AS,Kinter LB,et al. The application of toxicokinetic data to doasage selection in toxicology studies[J].Toxicol Pathol,1994,22(2):112-123.
  • 3Schwartz S.Providing toxicokinetic support for reproductive toxicology studies in pharmaceutical development[J].Arch Toxicol,2001,75(7): 381-387.
  • 4Sjoberg P. Toxicokinentics in preclinical safety assessment-views from the Swedish Medical products Agency[J].Drug Inf J,1994,28:151-157.
  • 5Smith DA,Humphrey MJ,Charuel C. Design of toxicokinetic studies[J].Xenobiotica,1990,20(11):1187-1199.
  • 6Dixit R,Riviere J,Krishnan K,et al. Toxicokinetics and physiologically based toxicokinetics in toxicology and risk assessment[J].J Toxicol Environ Health B Crit Rev,2003,6(1): 1-40.
  • 7Zhong WZ,Williams MG.Branstetter Toxicokinetics in drug development: an overview of toxicokinetic application in the development of PNU-101017,an anxiolytic drug candidate[J].Curr Drug Metab,2000,1(3): 243-254.
  • 8Buchanan JR,Burka LT,Melnick RL. Purpose and guidelines for toxicokinetic studies within the National Toxicology Program[J].Environ Health Perspect,1997,105(5): 468-471.
  • 9Van Asperen J,Rijcken WR,Lammers JH. Application of physiologically based toxicokinetic modelling to study the impact of the exposure scenario on the toxicokinetics and the behavioural effects of toluene in rats[J].Toxicol Lett,2003,138(1-2): 51-62.
  • 10Mushak P.New directions in the toxicokinetics of human lead exposure[J].Neurotoxicology,1993,14(2-3): 29-42.

共引文献31

同被引文献87

引证文献7

二级引证文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部